US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROGENE INC

20.09

+0.34001.72%

Post-market: 20.230.1400+0.70%16:15 EDT

Volume:75.54K

Turnover:1.51M

Market Cap:286.52M

PE:-4.62

High:20.71

Open:20.02

Low:19.01

Close:19.75

Loading ...

Overview Company News Filings

Neurogene announces peer-reviewed publication of EXACT transgene technology

Biotech stocks slide as Marks resignation seen being negative for sector

Neurogene files $300M mixed securities shelf

Neurogene price target lowered to $38 from $46 at Baird

Neurogene Is Maintained at Buy by HC Wainwright & Co.

Neurogene Inc reports results for the quarter ended December 31 - Earnings Summary

Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY

BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing

Neurogene Inc: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing

THOMSON REUTERS

BRIEF-Neurogene FY Net Income USD -75.144 Million

Neurogene Inc - Regulatory Update on Ngn-401 Trial Plans Expected in H1 2025

THOMSON REUTERS

Neurogene Inc: Cash Runway Into Second Half of 2027

THOMSON REUTERS

Neurogene FY Operating Income USD -82.605 Million

THOMSON REUTERS

Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates

THOMSON REUTERS

Press Release: Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Neurogene to Participate in Upcoming Conferences

Neurogene Insiders Placed Bullish Bets Worth US$1.46m

Simply Wall St.

Stifel Nicolaus Keeps Their Buy Rating on Neurogene (NGNE)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NGNE/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGNE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":20.09,"timestamp":1751562000000,"preClose":19.75,"halted":0,"volume":75541,"hourTrading":{"tag":"盘后","latestPrice":20.23,"preClose":20.09,"latestTime":"16:15 EDT","volume":729,"amount":14635.07,"timestamp":1751573744148},"delay":0,"floatShares":3232652,"shares":14262066,"eps":-4.352455,"marketStatus":"Closed Independence Day","change":0.34,"latestTime":"07-03 13:00:00 EDT","open":20.02,"high":20.71,"low":19.01,"amount":1505879.453985,"amplitude":0.086076,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.352455,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":19.75,"preHourTrading":{"tag":"盘前","latestPrice":19.75,"preClose":19.75,"latestTime":"08:00 EDT","volume":3,"amount":59.25,"timestamp":1751544001678},"postHourTrading":{"tag":"盘后","latestPrice":20.23,"preClose":20.09,"latestTime":"16:15 EDT","volume":729,"amount":14635.07,"timestamp":1751573744148},"volumeRatio":0.2983687677256543,"impliedVol":1.4119,"impliedVolPercentile":0.8829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","floatShares":3232652,"roa":"-21.97%","roe":"-34.97%","lyrEps":-4.277545,"volumeRatio":0.2983687677256543,"shares":14262066,"dividePrice":0,"high":20.71,"amplitude":0.086076,"preClose":19.75,"low":19.01,"week52Low":6.875,"pbRate":"0.98","psRate":"309.76","week52High":74.49,"institutionHeld":0,"latestPrice":20.09,"eps":-4.352455,"divideRate":0,"volume":75541,"delay":0,"ttmEps":-4.352455,"open":20.02,"prevYearClose":22.86,"prevWeekClose":16.16,"prevMonthClose":14.95,"prevQuarterClose":14.95,"fiveDayClose":16.57,"twentyDayClose":21.67,"sixtyDayClose":7.865},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGNE\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524446541","title":"Neurogene announces peer-reviewed publication of EXACT transgene technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2524446541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524446541?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:06","pubTimestamp":1743624400,"startTime":"0","endTime":"0","summary":"The company states: “Neurogene (NGNE) announced a peer-reviewed publication on its EXACT transgene regulation technology. The preclinical studies d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-announces-peer-reviewed-publication-of-exact-transgene-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-announces-peer-reviewed-publication-of-exact-transgene-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RCKT","MRNA","IE00B4R5TH58.HKD","BK4578","DYN","PTCT","MGX","LU0823416689.USD","FDMT","LU1066053197.SGD","LU2468319806.SGD","DTIL","SRPT","BK4007","PRME","RCKTW","TSHA","NGNE","IE0002141913.USD","IE00B3T34201.USD","LU2462157665.USD","LU0417517546.SGD","BK4568","VRTX","IE00BZ9MQY76.HKD","GLPG","BK4551","NTLA","CRSP","KPTI","VERV","GILD","BK4532","MGTX","BEAM","BK4139","LU1571399168.USD","LU1035775433.USD","LU2023250504.SGD","LEGN","LU2362540622.SGD","REGN","LU1066051498.USD","PCRX","LU1069344957.HKD","LU1430594728.SGD","RGNX","LU0058720904.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","RNA"],"gpt_icon":1},{"id":"2522750884","title":"Neurogene files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2522750884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522750884?lang=en_us&edition=fundamental","pubTime":"2025-03-26 03:18","pubTimestamp":1742930338,"startTime":"0","endTime":"0","summary":"16:35 EDT Neurogene (NGNE) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522881034","title":"Neurogene price target lowered to $38 from $46 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2522881034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522881034?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:59","pubTimestamp":1742929142,"startTime":"0","endTime":"0","summary":"Baird analyst Joel Beatty lowered the firm’s price target on Neurogene (NGNE) to $38 from $46 and keeps an Outperform rating on the shares. The fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-price-target-lowered-to-38-from-46-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-price-target-lowered-to-38-from-46-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522291260","title":"Neurogene Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522291260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522291260?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:32","pubTimestamp":1742902320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NGNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 07:32 ET (11:32 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE"],"gpt_icon":0},{"id":"2522085674","title":"Neurogene Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522085674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522085674?lang=en_us&edition=fundamental","pubTime":"2025-03-25 05:33","pubTimestamp":1742851983,"startTime":"0","endTime":"0","summary":"Neurogene Inc reports results for the quarter ended December 31 - Earnings SummaryNeurogene Inc NGNE.OQ reported a quarterly adjusted loss of 99 cents per share for the quarter ended December 31, high","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q7201:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE"],"gpt_icon":0},{"id":"2522088469","title":"Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2522088469","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522088469?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:53","pubTimestamp":1742849638,"startTime":"0","endTime":"0","summary":"Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44465862/neurogene-q4-net-profit-19-5-m-down-from-2-4m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522263700","title":"BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522263700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522263700?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:38","pubTimestamp":1742848737,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC FilingMarch 24  - Neurogene Inc NGNE.O:NEUROGENE INC: FILES FOR MIXED SHELF OFFERING OF UP TO $300 MILLION - SEC FILINGSource text: [ID:n0001628280-25-014521]Further company coverage: NGNE.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q71D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522700424","title":"Neurogene Inc: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522700424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522700424?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:35","pubTimestamp":1742848557,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q71D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522707976","title":"BRIEF-Neurogene FY Net Income USD -75.144 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707976?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847045,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene FY Net Income USD -75.144 Million\n\n\nMar 24 (Reuters) - Neurogene FY operating income USD -82.605 million.\n\nFY operating expenses USD 83.53 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522707970","title":"Neurogene Inc - Regulatory Update on Ngn-401 Trial Plans Expected in H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707970?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522707942","title":"Neurogene Inc: Cash Runway Into Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707942?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522707613","title":"Neurogene FY Operating Income USD -82.605 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707613?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522707697","title":"Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707697?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA5TNLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522770718","title":"Press Release: Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522770718","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522770718?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":"Remains on track to provide regulatory update on registrational trial plans with NGN-401 for Rett syndrome in the first half of 2025. Continues to expect to share additional interim clinical data from NGN-401 Phase 1/2 trial in the second half of 2025. Received PRIME designation for NGN-401 from the European Medicines Agency. Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced fourth quarter and full year 2024 financial results and highlighted recent corporate updates.Fourth Quarter 2024 and Recent Highlights, and Anticipated Milestones. -- Protocol amended and submitted to U.S. Food and Drug Administration . participants expected to be dosed during the first half of the year","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4099","BK4555","BK4604","IE00B1BXHZ80.USD","BK4006","CMC","BK4585","BK4588","IE00BHPRN162.USD","LU1363072403.SGD","BK4139","LU0971096721.USD","03160","IE00BKVL7J92.USD","LU0149725797.USD","IE00BZ1G4Q59.USD","LU0170899867.USD","LU0267386448.USD","LU0882574139.USD","NGNE"],"gpt_icon":0},{"id":"2521037934","title":"North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2521037934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521037934?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:02","pubTimestamp":1742551320,"startTime":"0","endTime":"0","summary":"The euphoria from the Federal Reserve's policy meeting didn't last long.Stock futures were lower Friday as attention shifted from the Fed to the prospect of further tariffs.Trump said in a social media post that the planned imposition of reciprocal tariffs on April 2 would be \"Liberation Day\" in the U.S.\"We maintain our view that the FOMC outcome was effectively a one-day move, with minimal legacy in terms of immediate direction. That said, we also view the FOMC outcome as a whole as nodding towards dovishness, but with numerous caveats,\" ING said.Quantum-computing stocks  are likely to be in focus after suffering steep falls on Thursday as investors appeared unimpressed by their contributions to Nvidia's Quantum Day at its GTC developers' event.The market also faces a test as an estimated $4.5 trillion in options contracts expire, which could increase volatility.FedEx fell 5.1% off hours after it cut its outlook for the year.Lennar management warned investors of a weak housing market.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US30Y.BOND","SMXT","NVDS","US2Y.BOND","CCL","NVDD","US5Y.BOND","SNVD.UK","US6M.BOND","AFG","PRPH","ZBIO","IMNM","GORV","3NVD.UK","JVA","BOLD","OLMA","US7Y.BOND","FBLG","NVD2.UK","FBRX","NVDL","USAU","ATXI","CKPT","NVDY","SGMA","NVDS.UK","ADVM","MPU","NVIW.SI","NVDX","BPTH","PURE","NVD3.UK","XOMA","DM","US3Y.BOND","NVDA","NVDU","US10Y.BOND","DXYN","2NVD.UK","NGNE","US12M.BOND","ET","IRD","IMRX"],"gpt_icon":1},{"id":"2513725817","title":"Neurogene to Participate in Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2513725817","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513725817?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:30","pubTimestamp":1740400200,"startTime":"0","endTime":"0","summary":"NEW YORK, February 24, 2025----Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following conferences:. TD Cowen 45th Annual Health Care ConferenceFormat: Management will participate in a fireside chat and investor meetingsDate: Monday, March 3 at 9:50 a.m. ET. Leerink Global Healthcare ConferenceFormat: Management will participate in a fireside chat and investor meetingsDate: Monday, March 10 at 1:00 p.m. ET. Stifel Virtual CNS ForumFormat: Management will participate in a fireside chatDate: Wednesday, March 19 at 9:30 a.m. ET. Live webcasts of the fireside chats will be accessible from the Investor Relations section of Neurogene’s website under events, where a replay of the events will also be available for a limited time.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurogene-participate-upcoming-conferences-123000601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2511031671","title":"Neurogene Insiders Placed Bullish Bets Worth US$1.46m","url":"https://stock-news.laohu8.com/highlight/detail?id=2511031671","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511031671?lang=en_us&edition=fundamental","pubTime":"2025-02-15 20:45","pubTimestamp":1739623502,"startTime":"0","endTime":"0","summary":"Quite a few insiders have dramatically grown their holdings in Neurogene Inc.  over the past 12 months. An insider's optimism about the company's prospects is a positive sign.Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.The Last 12 Months Of Insider Transactions At Neurogene. The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. Given that insiders also own a fair bit of Neurogene we think they are probably pretty confident of a bright future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurogene-insiders-placed-bullish-bets-124502893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2510851137","title":"Stifel Nicolaus Keeps Their Buy Rating on Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510851137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510851137?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:45","pubTimestamp":1739191551,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Neurogene (NGNE – Research Report) today and set a price target of $46.00. The comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-neurogene-ngne-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-neurogene-ngne-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","NGNE"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGNE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"NGNE","fiscalQuarterEnding":"2025/03","expectedEps":-1.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-1.08},{"market":"US","date":"2025-03-24","symbol":"NGNE","fiscalQuarterEnding":"2024/12","expectedEps":-1.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.99},{"market":"US","date":"2024-11-18","symbol":"NGNE","fiscalQuarterEnding":"2024/09","expectedEps":-1.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731906000000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2024-08-09","symbol":"NGNE","fiscalQuarterEnding":"2024/06","expectedEps":-1.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-1.09},{"market":"US","date":"2024-05-10","symbol":"NGNE","fiscalQuarterEnding":"2024/03","expectedEps":-1.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGNE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGNE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1750219200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGNE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGNE","date":"2025-07-03","current":-3.543031,"percent":0.827778,"low":-19.523035,"twenty":-11.778088,"median":-7.622846,"eighty":-3.964273,"high":-1.458307,"avg":-8.112076,"sd":4.121543,"marketCap":286524905},"quantilePoints":[{"date":"2023-12-29","current":-4.323556,"twenty":-4.185645,"median":-3.978778,"eighty":-3.916869,"marketCap":220311097},{"date":"2024-01-05","current":-5.423319,"twenty":-5.000527,"median":-4.624292,"eighty":-3.978778,"marketCap":276350648},{"date":"2024-01-12","current":-8.005373,"twenty":-7.157271,"median":-5.423319,"eighty":-4.323556,"marketCap":407921769},{"date":"2024-01-19","current":-7.59768,"twenty":-7.599292,"median":-7.086806,"eighty":-4.804734,"marketCap":387147382},{"date":"2024-01-26","current":-8.053188,"twenty":-7.611677,"median":-7.561189,"eighty":-4.985427,"marketCap":410358272},{"date":"2024-02-02","current":-7.741127,"twenty":-7.937424,"median":-7.577547,"eighty":-5.338761,"marketCap":394456888},{"date":"2024-02-09","current":-7.497015,"twenty":-7.980207,"median":-7.59013,"eighty":-6.388695,"marketCap":382017903},{"date":"2024-02-16","current":-7.549864,"twenty":-7.937424,"median":-7.577547,"eighty":-6.995453,"marketCap":384710880},{"date":"2024-02-23","current":-7.622846,"twenty":-7.894138,"median":-7.57503,"eighty":-7.129085,"marketCap":388429751},{"date":"2024-03-01","current":-7.819143,"twenty":-7.894138,"median":-7.588872,"eighty":-7.262969,"marketCap":398432234},{"date":"2024-03-08","current":-9.734292,"twenty":-8.024499,"median":-7.59768,"eighty":-7.381754,"marketCap":496020561},{"date":"2024-03-15","current":-8.697444,"twenty":-8.083388,"median":-7.629138,"eighty":-7.463796,"marketCap":443186933},{"date":"2024-03-22","current":-17.419498,"twenty":-9.10262,"median":-7.660596,"eighty":-7.498525,"marketCap":632623921},{"date":"2024-03-28","current":-17.433655,"twenty":-9.373408,"median":-7.741127,"eighty":-7.499532,"marketCap":633138041},{"date":"2024-04-05","current":-15.090764,"twenty":-9.721205,"median":-7.845567,"eighty":-7.510605,"marketCap":548051280},{"date":"2024-04-12","current":-13.565408,"twenty":-14.180505,"median":-7.97769,"eighty":-7.536275,"marketCap":492654915},{"date":"2024-04-19","current":-11.176509,"twenty":-13.912948,"median":-8.029281,"eighty":-7.549864,"marketCap":405897266},{"date":"2024-04-26","current":-10.571321,"twenty":-13.650346,"median":-8.053188,"eighty":-7.549864,"marketCap":383918661},{"date":"2024-05-03","current":-12.537284,"twenty":-13.442874,"median":-8.146303,"eighty":-7.558924,"marketCap":455316556},{"date":"2024-05-10","current":-11.764996,"twenty":-13.2542,"median":-9.074937,"eighty":-7.57352,"marketCap":427269365},{"date":"2024-05-17","current":-10.587696,"twenty":-13.13876,"median":-9.272492,"eighty":-7.576037,"marketCap":433830864},{"date":"2024-05-24","current":-9.887502,"twenty":-12.800854,"median":-9.44488,"eighty":-7.581574,"marketCap":405140389},{"date":"2024-05-31","current":-10.685033,"twenty":-12.52136,"median":-9.620612,"eighty":-7.588117,"marketCap":437819226},{"date":"2024-06-07","current":-11.771752,"twenty":-12.409114,"median":-9.810897,"eighty":-7.59013,"marketCap":482347539},{"date":"2024-06-14","current":-13.301826,"twenty":-12.457666,"median":-9.93146,"eighty":-7.59013,"marketCap":545042335},{"date":"2024-06-21","current":-9.842528,"twenty":-12.564112,"median":-9.93146,"eighty":-7.59617,"marketCap":403297579},{"date":"2024-06-28","current":-11.030474,"twenty":-12.52136,"median":-10.019377,"eighty":-7.599292,"marketCap":451973662},{"date":"2024-07-05","current":-11.397945,"twenty":-12.537284,"median":-10.188931,"eighty":-7.605739,"marketCap":467030798},{"date":"2024-07-12","current":-13.232134,"twenty":-12.537284,"median":-10.458961,"eighty":-7.622846,"marketCap":542186671},{"date":"2024-07-15","current":-13.48873,"twenty":-12.644595,"median":-10.463671,"eighty":-7.625363,"marketCap":552700705},{"date":"2024-08-02","current":-12.832984,"twenty":-12.76836,"median":-10.468381,"eighty":-7.627879,"marketCap":525831507},{"date":"2024-08-09","current":-11.578513,"twenty":-12.617767,"median":-10.579508,"eighty":-7.644992,"marketCap":474429562},{"date":"2024-08-16","current":-9.721942,"twenty":-12.533918,"median":-10.468381,"eighty":-7.659841,"marketCap":462832495},{"date":"2024-08-23","current":-9.22793,"twenty":-12.500388,"median":-10.20777,"eighty":-7.686769,"marketCap":439314055},{"date":"2024-08-30","current":-9.934831,"twenty":-12.3607,"median":-10.082175,"eighty":-7.732068,"marketCap":472967513},{"date":"2024-09-06","current":-9.383503,"twenty":-12.215183,"median":-10.030358,"eighty":-7.751697,"marketCap":446720414},{"date":"2024-09-13","current":-11.015654,"twenty":-12.198503,"median":-10.056266,"eighty":-7.799009,"marketCap":524422220},{"date":"2024-09-20","current":-11.343175,"twenty":-12.111032,"median":-10.20463,"eighty":-7.829713,"marketCap":540014556},{"date":"2024-09-27","current":-10.69359,"twenty":-12.018852,"median":-10.282823,"eighty":-7.883065,"marketCap":509089757},{"date":"2024-10-04","current":-12.12104,"twenty":-12.018852,"median":-10.468381,"eighty":-7.937424,"marketCap":577046353},{"date":"2024-10-11","current":-13.141817,"twenty":-12.215183,"median":-10.579508,"eighty":-7.980207,"marketCap":625642465},{"date":"2024-10-18","current":-14.443716,"twenty":-12.644595,"median":-10.678753,"eighty":-7.993293,"marketCap":687621999},{"date":"2024-10-25","current":-13.155463,"twenty":-12.975228,"median":-10.69616,"eighty":-8.014936,"marketCap":626292146},{"date":"2024-10-31","current":-11.938174,"twenty":-12.976568,"median":-10.764003,"eighty":-8.053188,"marketCap":568340632},{"date":"2024-11-08","current":-18.968977,"twenty":-13.201862,"median":-10.833215,"eighty":-8.053188,"marketCap":903056103},{"date":"2024-11-15","current":-10.699049,"twenty":-13.232134,"median":-10.867118,"eighty":-8.053188,"marketCap":509349629},{"date":"2024-11-22","current":-3.804354,"twenty":-13.201862,"median":-10.811892,"eighty":-8.005373,"marketCap":202570426},{"date":"2024-11-29","current":-7.081932,"twenty":-13.164743,"median":-10.73726,"eighty":-7.916284,"marketCap":377091628},{"date":"2024-12-06","current":-6.123936,"twenty":-13.144546,"median":-10.69616,"eighty":-7.738107,"marketCap":326081199},{"date":"2024-12-13","current":-6.220014,"twenty":-13.009618,"median":-10.678753,"eighty":-7.632912,"marketCap":331197071},{"date":"2024-12-20","current":-6.147607,"twenty":-12.971208,"median":-10.579508,"eighty":-7.59013,"marketCap":327341631},{"date":"2024-12-27","current":-6.711544,"twenty":-12.908645,"median":-10.50763,"eighty":-7.57654,"marketCap":357369573},{"date":"2025-01-03","current":-6.374574,"twenty":-12.853892,"median":-10.405691,"eighty":-7.549864,"marketCap":339426951},{"date":"2025-01-10","current":-5.995231,"twenty":-12.800672,"median":-10.212067,"eighty":-7.505069,"marketCap":319228040},{"date":"2025-01-17","current":-4.918377,"twenty":-12.651961,"median":-10.173232,"eighty":-7.427764,"marketCap":261888801},{"date":"2025-01-24","current":-4.346472,"twenty":-12.574112,"median":-10.030358,"eighty":-7.086806,"marketCap":231436615},{"date":"2025-01-31","current":-4.332524,"twenty":-12.537284,"median":-9.920586,"eighty":-6.842433,"marketCap":230693879},{"date":"2025-02-07","current":-6.50018,"twenty":-12.535901,"median":-9.842528,"eighty":-6.605719,"marketCap":346115092},{"date":"2025-02-14","current":-5.236411,"twenty":-12.52887,"median":-9.777894,"eighty":-6.491539,"marketCap":278823188},{"date":"2025-02-21","current":-4.829104,"twenty":-12.471907,"median":-9.750601,"eighty":-6.430271,"marketCap":257135289},{"date":"2025-02-28","current":-4.770518,"twenty":-12.349943,"median":-9.721942,"eighty":-6.303838,"marketCap":254015797},{"date":"2025-03-07","current":-4.672876,"twenty":-12.236804,"median":-9.661093,"eighty":-6.2189,"marketCap":248816643},{"date":"2025-03-14","current":-4.686825,"twenty":-12.214976,"median":-9.588204,"eighty":-6.130619,"marketCap":249559380},{"date":"2025-03-21","current":-4.24883,"twenty":-12.149292,"median":-9.555425,"eighty":-6.004158,"marketCap":226237461},{"date":"2025-03-28","current":-3.045755,"twenty":-12.12341,"median":-9.468113,"eighty":-5.45457,"marketCap":228870246},{"date":"2025-04-04","current":-1.92123,"twenty":-12.043093,"median":-9.418302,"eighty":-5.225252,"marketCap":144368903},{"date":"2025-04-11","current":-1.782154,"twenty":-12.004592,"median":-9.374415,"eighty":-5.034123,"marketCap":133918207},{"date":"2025-04-17","current":-2.044108,"twenty":-11.997937,"median":-9.328916,"eighty":-4.961897,"marketCap":153602450},{"date":"2025-04-25","current":-2.917172,"twenty":-11.976697,"median":-9.167755,"eighty":-4.922368,"marketCap":219207954},{"date":"2025-05-02","current":-2.922866,"twenty":-11.956745,"median":-9.074937,"eighty":-4.83359,"marketCap":219635816},{"date":"2025-05-09","current":-2.846947,"twenty":-11.943832,"median":-8.430682,"eighty":-4.764939,"marketCap":213930990},{"date":"2025-05-16","current":-3.416053,"twenty":-11.921952,"median":-8.053188,"eighty":-4.703006,"marketCap":276256218},{"date":"2025-05-23","current":-3.181497,"twenty":-11.907794,"median":-8.053188,"eighty":-4.667296,"marketCap":257287670},{"date":"2025-05-30","current":-3.304948,"twenty":-11.891321,"median":-7.997823,"eighty":-4.63103,"marketCap":267271116},{"date":"2025-06-06","current":-4.042124,"twenty":-11.854896,"median":-7.927357,"eighty":-4.432955,"marketCap":326886552},{"date":"2025-06-13","current":-3.597702,"twenty":-11.83216,"median":-7.80656,"eighty":-4.329176,"marketCap":290946146},{"date":"2025-06-20","current":-3.22735,"twenty":-11.824338,"median":-7.733577,"eighty":-4.305184,"marketCap":260995807},{"date":"2025-06-27","current":-2.922251,"twenty":-11.790759,"median":-7.659337,"eighty":-4.202034,"marketCap":236322433},{"date":"2025-07-03","current":-3.543031,"twenty":-11.778088,"median":-7.622846,"eighty":-3.964273,"marketCap":286524905}],"updateTime":1751633088609}}}